An E3 ubiquitin-proteasome gene signature for predicting prognosis in patients with pancreatic cancer.

Front Immunol · 2023 · PMC10830689 · PMID 38304253

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, risk genes (TRIM5, NUP37, DTX3L) showed a trend of high expression in the high risk group, while protective genes (WDR5, WDR37, TLE2, RNF167, GNB3, ANAPC2) showed a high expression trend in the low risk group ( Figure 2I ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.